Ross procedure continues to impress | FDA approves drug label changes | The first operation of its kind | Mental health & CVD

TAVR may get more attention, but the Ross procedure has also gained significant momentum in recent years. Ismail El-Hamamsy, MD, PhD, detailed his own team's success with the complex procedure.

The FDA listened to physician feedback and updated its labeling requirements for fenofibrates. These drugs have not been linked to any significant cardiovascular benefits, and clinicians should act accordingly.

When a 50-year-old patient developed severe TR just months after receiving a heart transplant, the safest treatment option was to implant an Evoque TTVR device. 

Different subtypes of depression are association with specific cardiometabolic diseases, according to new data out of the Netherlands. 

Peter Weiss, MD, a veteran electrophysiologist, sat down with Cardiovascular Business to discuss the ongoing rise of pulsed field ablation. While he's impressed with the technology, he says many questions remain about its long-term value. 

The FDA has finalized new Class I recalls related to ongoing safety concerns with Boston Scientific’s Accolade family of pacemakers. A software update is now available to help address the issue, and an additional update is already in the works.

Going forward, Medtronic can include clinical evidence related to the treatment of ruptured abdominal aortic aneurysms in the device's labeling. This is the first time an EVAR system has received such an approval.

The surgeon has been accused of performing multiple procedures she was not skilled enough to take on. After undergoing additional training, she could soon return to the job—and her colleagues are not happy.

"There is already a deficit of doctors in the U.S., and this will make it worse," one cardiologist told Cardiovascular Business. Medical societies throughout the country seem to agree. 

The FDA-cleared device from Medtronic, which arrives pre-loaded on a single-use delivery system, is now set to launch in Europe.

Five of the seven MACs recently released proposed local coverage determinations, pertaining to peripheral nerve blocks. 

Sudesh Ebenezer, MD, claims Hurley Medical Center retaliated against him after he expressed concerns over the incident. He is seeking unspecified damages.